共 14 条
- [1] ASO Author Reflections: Bi-Directional Chemotherapy Using PIPAC Could Downstage Nonresectable Malignant Peritoneal Mesothelioma Patients to a Complete Resection [J]. Annals of Surgical Oncology, 2022, 29 : 2114 - 2115
- [2] ASO Author Reflections: Normothermic Intraperitoneal Chemotherapy Long-Term for Malignant Peritoneal Mesothelioma [J]. Annals of Surgical Oncology, 2021, 28 : 7118 - 7119
- [6] ASO Author Reflections: International Standardization of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Protocols—Malignant Peritoneal Mesothelioma as a Model [J]. Annals of Surgical Oncology, 2023, 30 : 7858 - 7859
- [7] ASO Author Reflections: Perioperative Systemic Chemotherapy in Diffuse Malignant Peritoneal Mesothelioma treated with CRS-HIPEC [J]. Annals of Surgical Oncology, 2024, 31 : 2511 - 2512
- [10] Non-resectable Malignant Peritoneal Mesothelioma Treated with Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Plus Systemic Chemotherapy Could Lead to Secondary Complete Cytoreductive Surgery: A Cohort Study [J]. Annals of Surgical Oncology, 2022, 29 : 2104 - 2113